MINDEROO-FOUNDATION
9.5.2022 08:23:07 CEST | Business Wire | Press release
A cutting-edge new tool developed by Minderoo Foundation has identified thousands of waste sites across 25 countries for the first time using advanced satellite data technology and machine learning to measure piles of plastic waste from space.
Global Plastic Watch (globalplasticwatch.org ) is a tool which combines earth observation with artificial intelligence to create the first-ever near-real-time high-resolution map of plastic pollution. This is the largest open-source dataset of plastic waste across dozens of countries. The aim of the tool is to help authorities to better manage plastic leakage into the marine environment.
Global Plastic Watch uses remote sensing satellite imagery from the European Space Agency and a first-of-its-kind machine learned model created in collaboration with award winning Digital Product Agency for the Environment, Earthrise Media . The tool is able to determine the size and scale of land-based plastic waste sites, a major factor in fueling the growing problem of plastic pollution of the world’s rivers and oceans.
The data gathered provides a historical first and authoritative insight into one of the world’s most intractable environmental challenges – a deluge of plastic pollution which is threatening the oceans, harming communities, marine life, animal and human health. By using it, governments, industry and communities can evaluate and monitor the risk of land-based plastic waste sites, as well as prioritise investments in solutions.
The countries mapped so far include all of South-East Asia, Australia, and the countries identified by research published in Science Advances as accounting for high rates of plastic emissions into the ocean.
Dr Andrew Forrest AO, Chairman and Co-Founder of the Minderoo Foundation described data and transparency as important tools to fight plastic waste, and until now, it has been difficult to effectively identify and measure plastic waste build-up in a systematic, standardised way.
“Generally, the world has no idea how dangerous plastic waste is to the organic environment, particularly humans. The destination for every piece of plastic is nano-plastic, which has both poisonous and cutting attributes able to mutilate cells and even penetrate the human blood brain barrier,” Dr Forrest said.
“Preventing illegal and legal plastic waste stockpiles entering the oceanic environment is critical to limit this harm. Once in the ocean, through both mixing, absorption and ingestion by animals, this plastic will officially enter the human environment.
Using artificial Intelligence and satellite data, Minderoo Foundation has produced the first-ever map of plastic waste build up. Most of our data about plastic waste comes from models and estimates. Now our understanding is informed by real data that can be used to guide solutions.
Global Plastic Watch arms governments and researchers around the world with data that can better guide effective waste management interventions, ensuring land-based waste doesn’t end up in our oceans,” Dr Forrest said. “We want to work with governments to ensure this tool can also help to support policy change where needed.”
Dr Fabien Laurier, Lead for Technology and Innovation, and Ocean Conservation at Minderoo Foundation said some of the Global Plastic Watch findings were surprising.
“We know that land-based leakage contributes up to 91 per cent of the plastic waste that enters the ocean,” Dr Laurier said. “Global Plastic Watch has revealed that many large-scale waste sites across the first 25 countries we have mapped were previously undocumented and the number of sites is much higher than expected.”
The government of Indonesia is working with Minderoo Foundation to increase its recycling capacity to double recycling rates by developing capacity for an additional one million tonnes per year by 2025.
Dr Nani Hendiarti, Deputy for Environment and Forestry Management Coordination, Coordinating Ministry for Maritime Affairs and Investment, Indonesia, congratulated Minderoo Foundation on the public launch of the Global Plastic Watch.
“Global Plastic Watch is very helpful for identifying undocumented or illegal waste dump sites in Indonesia,” Dr Hendiarti said. “That has enabled us to prioritise areas in need of better waste management policies and actions. Therefore, it plays an integral role in accelerating the government’s waste management achievements across all regions in the country.”
Indonesian National Plastic Action Partnership (NPAP) Chair, Sri Indrastuti Hadiputranto, said tackling the challenge of plastic pollution in Indonesia, like in many other places in the world is going to require a collaborative effort from the public, private and civil society sectors, and its measurement is without exception.
“Global Plastic Watch is a data aggregator and monitoring platform on plastic waste,” Ms. Hadiputranto said. “It’s a timely innovation for policymakers, practitioners and advocates that believe in the importance of evidence-based policy making to advance our goal in reducing 70 per cent of ocean leakage by 2025. I believe more data-oriented innovations like Global Plastic Watch will lead us to a more sustainable policy outcome and improving collaborations in data collections in Indonesia.”
Global Plastic Watch is a tool aimed at supporting country-level efforts to understand the magnitudes and effects of land-based plastic waste sites, to enable them to better address undocumented sites and monitor those that pose environmental and health concerns. The data is also expected to guide direct investments in waste infrastructure in the areas that need it the most.
The development of the Global Plastic Watch tool follows the Plastic Waste Makers Index released in 2021, that revealed the true scale and sources of the global plastic waste crisis.
Globally, a 30 per cent increase in the production of single-use plastic is projected over the next five years. The Minderoo Foundation No Plastic Waste initiative believes this growth in production will lead to an extra three trillion items of throwaway plastic waste by 2025.
Global Plastic Watch will continue to work with partners to refine the Artificial Intelligence model and technology to further increase its accuracy as it expands its coverage to new sites and countries throughout 2022.
Global Plastic Watch site:
globalplasticwatch.org
Global Plastic Watch project site:
Minderoo.org/global-plastic-watch/
LINK TO PHOTOS (Password: k3YBL4TciY) | INTERVIEWS AND B-ROLL HERE | 2:17 VIDEO EDIT WITH ENGLISH NARRATION HERE |
About Minderoo Foundation:
Established by Andrew and Nicola Forrest in 2001, Minderoo Foundation is a modern philanthropic organisation seeking to break down barriers, innovate and drive positive, lasting change. Minderoo Foundation is proudly Australian, with key initiatives spanning from ocean research and ending slavery, to collaboration against cancer and building community projects.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220508005107/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
